APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma VL Cannataro, SG Gaffney, T Sasaki, N Issaeva, NKS Grewal, JR Grandis, ... Oncogene 38 (18), 3475-3487, 2019 | 90 | 2019 |
Effect sizes of somatic mutations in cancer VL Cannataro, SG Gaffney, JP Townsend JNCI: Journal of the National Cancer Institute 110 (11), 1171-1177, 2018 | 74 | 2018 |
Structural and practical identifiability issues of immuno-epidemiological vector–host models with application to rift valley fever N Tuncer, H Gulbudak, VL Cannataro, M Martcheva Bulletin of mathematical biology 78, 1796-1827, 2016 | 68 | 2016 |
Molecular biology and evolution of cancer: from discovery to action JA Somarelli, H Gardner, VL Cannataro, EF Gunady, AM Boddy, ... Molecular biology and evolution 37 (2), 320-326, 2020 | 64 | 2020 |
Nature inspired supply chain solutions: definitions, analogies, and future research directions N Turken, V Cannataro, A Geda, A Dixit International Journal of Production Research 58 (15), 4689-4715, 2020 | 40 | 2020 |
Neutral theory and the somatic evolution of cancer VL Cannataro, JP Townsend Molecular biology and evolution 35 (6), 1308-1315, 2018 | 38 | 2018 |
Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C VL Cannataro, SG Gaffney, C Stender, ZM Zhao, M Philips, AE Greenstein, ... Oncogene 37 (18), 2444-2455, 2018 | 32 | 2018 |
Vector-borne pathogen and host evolution in a structured immuno-epidemiological system H Gulbudak, VL Cannataro, N Tuncer, M Martcheva Bulletin of mathematical biology 79 (2), 325-355, 2017 | 31 | 2017 |
The implications of small stem cell niche sizes and the distribution of fitness effects of new mutations in aging and tumorigenesis VL Cannataro, SA McKinley, CM St. Mary Evolutionary applications 9 (4), 565-582, 2016 | 19 | 2016 |
Optimal sampling strategies for detecting zoonotic disease epidemics JM Ferguson, JB Langebrake, VL Cannataro, AJ Garcia, EA Hamman, ... PLoS computational biology 10 (6), e1003668, 2014 | 19 | 2014 |
Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma L Lu, SG Gaffney, VL Cannataro, J Townsend Oral oncology 101, 104554, 2020 | 18 | 2020 |
Attribution of cancer origins to endogenous, exogenous, and preventable mutational processes VL Cannataro, JD Mandell, JP Townsend Molecular Biology and Evolution 39 (5), msac084, 2022 | 14 | 2022 |
Environmental and sex-specific molecular signatures of glioma causation EB Claus, VL Cannataro, SG Gaffney, JP Townsend Neuro-oncology 24 (1), 29-36, 2022 | 14 | 2022 |
The evolutionary trade‐off between stem cell niche size, aging, and tumorigenesis VL Cannataro, SA McKinley, CM St. Mary Evolutionary applications 10 (6), 590-602, 2017 | 14 | 2017 |
Identifying modules of cooperating cancer drivers MI Klein, VL Cannataro, JP Townsend, S Newman, DF Stern, H Zhao Molecular systems biology 17 (3), e9810, 2021 | 13 | 2021 |
Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials JF Wilkins, VL Cannataro, B Shuch, JP Townsend Oncotarget 9 (32), 22243, 2018 | 11 | 2018 |
Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvement S Hanson, DR Grimes, JP Taylor-King, B Bauer, PI Warman, ... bioRxiv, 049908, 2016 | 9 | 2016 |
Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR JD Mandell, VL Cannataro, JP Townsend Cancer Research 83 (4), 500–505, 2023 | 8 | 2023 |
Wagging the long tail of drivers of prostate cancer VL Cannataro, JP Townsend PLoS Genetics 15 (1), e1007820, 2019 | 6 | 2019 |
Re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer. Eur Urol … A Yang, VL Cannataro, JP Townsend European Urology, e24-e25, 2019 | 5 | 2019 |